Why does menopausal hormone therapy lead to irregular uterine bleeding? Changes to endometrial blood vessels
article
OA: bronze
CC0
⤵ 5 in-corpus citations
Abstract
BACKGROUND: Abnormal bleeding is common in hormone therapy (HT) users. We aimed to determine how HT alters endometrial blood vessels and stromal factors known to regulate vascular growth and integrity. METHODS: Prospective observational study of 165 post-menopausal women in Western Australia. The following were measured in endometrial biopsies: vascular density (vessels/mm(2)), total vessel area (total area enclosed by peripheral vascular immunostaining for perivascular pericytes in mm(2)), total luminal area (mm(2)) and vessel wall area (total vessel area minus luminal area), stromal expression of matrix metalloproteinases (MMP) -1, -3, -9 and -14, their tissue inhibitors (TIMPs) -1-4 and vascular endothelial growth factor (VEGF) by immunohistochemistry. RESULTS: Total vessel area was greater during bleeding compared with HT users with no bleeding (P = 0.028) or with a prior irregular bleeding (P = 0.039). Total vessel area was greater in non-HT users compared with HT users with no bleeding (P = 0.021). In HT users, vessel luminal area was greater during bleeding compared with HT users with no bleeding (P = 0.030) and vessel wall area was also increased (P = 0.025). During bleeding there was an increase in stromal TIMP-2 staining (P = 0.044). No significant changes in endometrial MMP or VEGF were seen. CONCLUSIONS: Abnormal bleeding in HT users is associated with changes in endometrial vessel size and in stromal expression of factors known to regulate vascular growth and integrity. These changes may contribute to abnormal bleeding.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (18)
- A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness via openalex
- A functional model for progestogen-induced breakthrough bleeding via openalex
- Changes in endometrial blood vessels in the endometrium of women with hormone replacement therapy-related irregular bleeding via openalex
- Disturbances of endometrial bleeding with hormone replacement therapy via openalex
- Focal Expression and Final Activity of Matrix Metalloproteinases May Explain Irregular Dysfunctional Endometrial Bleeding via openalex
- Mechanisms of Irregular Bleeding with Hormone Therapy: The Role of Matrix Metalloproteinases and Their Tissue Inhibitors via openalex
- Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding via openalex
- doi:10.1093/molehr/3.9.735 via openalex
- doi:10.1210/jc.85.10.3853 via openalex
- doi:10.1016/s0002-9378(16)33500-1 via openalex
- doi:10.1210/jcem.85.10.6856 via openalex
- doi:10.1046/j.1600-0412.2003.00261.x via openalex
- doi:10.1210/jc.2005-0688 via openalex
- doi:10.1001/jama.288.3.321 via openalex
- doi:10.1016/s0015-0282(00)01690-3 via openalex
- doi:10.1093/humrep/15.1.1 via openalex
- doi:10.1080/cmt.4.1.58.74 via openalex
- doi:10.1002/jcp.1041570219 via openalex
Cited by (5)
- Abnormal Bleeding during Menopause Hormone Therapy: Insights for Clinical Management 2013
- Endometrial bleeding in postmenopausal women 2011
- Abnormal bleeding in postmenopausal hormone users—What do we know today? 2009
- Best Practice & Research Clinical Obstetrics and Gynaecology 2009
- Bleeding with menopausal hormone therapy 2008
Source provenance
- openalex
- last seen: 2026-05-11T05:53:22.067783+00:00
License: CC0
· commercial use OK